Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IMBI | Common Stock | Award | $50K | +16.3K | +22.56% | $3.07* | 88.5K | May 11, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IMBI | Warrants (right to buy) | Award | $0 | +16.3K | $0.00 | 16.3K | May 11, 2022 | Common Stock | 16.3K | $2.94 | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | This amendment is being filed solely to indicate transaction code "A" for all transactions reported because all reported purchases from the issuer were approved by the board or a committee of non-employee directors in accordance with Rule 16b-3(d). |
F2 | Once issued, exercisable upon the effective date of an amendment to the issuer's articles of incorporation to increase the number of authorized shares of the issuer's common stock to at least 40 million shares (such date, the "Effective Date"), which requires receipt of shareholder approval (such approval, "Shareholder Approval"), until the earlier of (a) five years from the Effective Date and (b) six years from the date of warrant issuance. |
F3 | Represents warrants that are to be issued to the registrant within 180 days of the receipt of Shareholder Approval. The issuer committed to issue such warrants in connection with its direct registered offering. |